SULT2A7 Inhibitors

The chemical class of SULT2A7 Inhibitors refers to compounds that can interfere with the sulfotransferase activity of SULT2A7, an enzyme that catalyzes the transfer of a sulfonyl group from the donor molecule PAPS to acceptor molecules, including hormones, neurotransmitters, and xenobiotic compounds. The mode of action of these inhibitors is generally characterized by their ability to compete with either the substrate or the cofactor for binding to the enzyme's active site.

Pentachlorophenol and 2,6-Dichloro-4-nitrophenol are examples of compounds that can inhibit SULT2A7 by direct competition at the catalytic site of the enzyme, preventing the binding and subsequent sulfonation of the enzyme's natural substrates. Flavonoids like quercetin and fisetin are known to interact with the sulfotransferase in a similar manner, potentially competing with PAPS for its binding site. This competition affects the enzyme's overall function by reducing the availability of the cofactor necessary for the sulfonation reaction to occur. Synthetic compounds such as triclosan, bisphenol A, and various phthalates, such as dibutyl phthalate and DEHP, can also interact with SULT2A7, likely by competing with natural substrates for access to the enzyme's active site. Pharmaceuticals like chlorpromazine and desipramine, which are known to inhibit other sulfotransferases, can be presumed to have a similar inhibitory effect on SULT2A7 due to their structural characteristics, which allow them to fit into the active site of the enzyme and block the normal enzymatic activity. These inhibitors collectively share the characteristic of modulating the enzymatic action of SULT2A7 by directly or indirectly preventing the binding of substrates or the cofactor required for the sulfation process.